Stock search

Ticker or company name

ResMed

RMD · NYSE · Health Care

$238,19Down −1,34 (−0,56%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$33,9 bn
Div. yield
1,2%
Year to date
−0,6%
52 weeks: $180,27$277,67

Ratio score

83/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

6 ✓ · 3 — · 0 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM21,328,125,1
Forward P/E18,4—16,2
PEG1,8—2,2
P/S5,97,12,2
EV/EBITDA16,721,817,3
P/FCF21,4—19,5
P/B5,76,43,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 27 analysts

Buy
14
Hold
11
Sell
2

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q1 20272,702,91Up +7,8%
Q4 20262,922,95Up +1,1%
Q3 20262,822,86Up +1,3%
Q2 20262,752,81Up +2,1%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue1,41 bn1,46 bn1,43 bn1,42 bn1,34 bn1,35 bn1,29 bn1,28 bn1,22 bn1,22 bn1,20 bn1,16 bn
EPS2,922,642,742,682,372,582,482,342,111,982,041,42
Margin29,6%26,2%27,9%27,6%26,1%28,2%28,3%26,9%25,4%23,9%25,1%18,0%
FCF374 m404 m520 m311 m414 m508 m558 m288 m308 m415 m381 m249 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $20,2 m.

NameAmountSharesPrice
farrell michael j.9 Nov 2026 · sale$1,18 m4 993$235,35
rider michael j23 Oct 2026 · sale$102 000400$255,00
farrell michael j.7 Oct 2026 · sale$1,13 m4 991$226,33
farrell michael j.8 Sep 2026 · sale$1,11 m4 991$222,44
farrell peter c2 Sep 2026 · sale$227 688970$234,73
farrell michael j.7 Aug 2026 · sale$1,03 m4 991$205,69
farrell peter c5 Aug 2026 · sale$1,80 m8 000$225,00
farrell michael j.7 Jul 2026 · sale$1,09 m4 991$218,55
farrell michael j.8 Jun 2026 · sale$968 0644 991$193,96
farrell michael j.7 May 2026 · sale$1,04 m4 991$207,82
farrell michael j.7 Apr 2026 · sale$1,13 m4 991$225,50
sandercock brett1 Apr 2026 · sale$224 3101 000$224,31
farrell peter c1 Apr 2026 · sale$450 0002 000$225,00
farrell michael j.9 Mar 2026 · sale$1,25 m4 991$251,03
farrell peter c4 Mar 2026 · sale$520 4402 000$260,22

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
1 Jun 1995

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
CNCCentene Corporation$74,7772would consider24,2+9,7%0,7%
DXCMDexcom$81,6189would consider31,4+13,0%19,4%
GEHCGE HealthCare$82,96no score17,4——
LHLabcorp$372,4656would watch30,0+6,0%6,9%
DGXQuest Diagnostics$262,2161would watch25,5+9,1%9,5%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.